Mochi Health vs Low-Cost GLP-1 Providers: September 2026 Pricing

Last reviewed: September 22, 2026 Last updated: September 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Mochi Health offers compounded semaglutide starting at $60/month for medication plus a $39 first-month membership (total $99), and compounded tirzepatide starting at $90/month medication plus the same membership (total $129), captured September 4, 2026 from joinmochi.com. Those figures represent starting-dose floors under Mochi's per-dose pricing model; medication cost increases as your clinician escalates your dose, and the ongoing membership rate after the first month requires confirmation at checkout—the published materials label the $39 rate as "first month" without documenting whether it continues or rises.

PlexusDx charges $189/month for compounded semaglutide injection and $289/month for compounded tirzepatide injection, flat rates at every dose with no membership fee. Seven other verified low-cost providers fall between $189–$299/month for semaglutide and $289–$399/month for tirzepatide on month-to-month plans, most using flat-rate structures. Mochi's 4.5-star Trustpilot rating (approximately 18,000 reviews, captured September 4, 2026) edges ahead of PlexusDx's 4.3-star profile (79% five-star, 83% four-star or higher, captured September 9, 2026; trustpilot.com/review/plexusdx.com).

The central trade-off: Mochi delivers the lowest documented entry price in this comparison, but its per-dose model shifts cost upward through treatment, and the membership question adds uncertainty beyond month one. PlexusDx and most competitors publish one predictable rate covering all doses. If you stay at Mochi's starting semaglutide dose and the $39 first-month membership (refill rate unconfirmed) holds, you pay $1,188 over 12 months versus $2,268 on PlexusDx (our calculation)—a $1,080 difference. As soon as your dose escalates, that gap narrows; evidence does not document Mochi's pricing at higher dose tiers, so you cannot model your total cost without contacting the provider.

At-a-glance: Mochi Health vs low-cost GLP-1 field

All pricing captured July 17–23, 2026 (benchmark providers) and September 4, 2026 (Mochi Health). Trustpilot ratings captured September 4 and 9, 2026. Compounded medications are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality.

Normalized pricing: like-for-like 12-month costs

Month-to-month plans expose the widest structural differences. Mochi Health separates medication from membership and ties medication cost to dose; most competitors bundle everything into one flat rate.

Mochi Health: entry pricing with escalation

At Mochi's starting semaglutide dose—$60 medication plus $39 first-month membership—you pay $99 in month one (captured September 4, 2026 from joinmochi.com/blog/per-dose-pricing-mochi-health and joinmochi.com/medications/compounded-tirzepatide). The evidence labels the $39 membership rate "first month" but does not document an ongoing rate, so we present two scenarios:

Scenario A: If the $39 membership continues unchanged, months 2–12 cost ($60 + $39) = $99 each, totaling $1,188 over 12 months, or $99/month effective (our calculation). Under the same assumption, starting-dose tirzepatide ($90 medication + $39 membership) totals $1,548 over 12 months, or $129/month effective (our calculation).

Scenario B: If the membership rate increases after month one—a common pattern when promotional language appears—the 12-month total rises by the difference multiplied across 11 months. Without evidence of the ongoing rate, we cannot calculate this scenario; readers must confirm membership terms at checkout.

Per-dose escalation: Mochi's model explicitly states that medication cost increases as your clinician raises your dose. The captured evidence confirms this structure but does not publish medication prices at higher dose tiers. A patient who escalates from starting semaglutide (captured at $60/month medication) to a maintenance dose will pay more than $60/month for medication, reducing or eliminating the cost advantage over flat-rate providers. The total cost through a typical dose-escalation journey cannot be modeled from available evidence.

PlexusDx and flat-rate benchmarks: predictable totals

PlexusDx charges $189/month for compounded semaglutide injection and $289/month for compounded tirzepatide injection (captured July 17–23, 2026 from plexusdx.com/pages/glp-1-alternatives). These rates apply at every dose—starting, escalation, and maintenance—with no membership fee. Over 12 months, semaglutide totals $2,268 and tirzepatide totals $3,468 (our calculation).

Other flat-rate month-to-month providers (all captured July 17–23, 2026):

• Eden: $198/month semaglutide ($99 medication + $99 membership) = $2,376 over 12 months; tirzepatide $298/month = $3,576 over 12 months (our calculation).
• Peak Wellness: $249/month semaglutide = $2,988 over 12 months; tirzepatide $349/month = $4,188 over 12 months (our calculation).
• Found cash-pay: $289/month semaglutide = $3,468 over 12 months; tirzepatide $359/month = $4,308 over 12 months (our calculation). Found also offers a 12-month prepaid plan at $169/month semaglutide when paid upfront—a prepaid discount, not a standard month-to-month rate.
• Henry Meds: $297/month semaglutide = $3,564 over 12 months (our calculation). Tirzepatide offered only as oral dissolving tablet; no published monthly injection rate.
• Embody: $299/month semaglutide = $3,588 over 12 months; tirzepatide $349/month = $4,188 over 12 months (our calculation).
• TrimRx: $299/month semaglutide (checkout-verified ongoing rate; advertised rate is $199) = $3,588 over 12 months; tirzepatide $399/month (checkout-verified; advertised $349) = $4,788 over 12 months (our calculation).

Head-to-head: Mochi starting dose vs PlexusDx

Semaglutide, 12 months, assuming Mochi's $39 first-month membership (refill rate unconfirmed) continues:

• Mochi Health (starting dose): $99/month effective = $1,188 total (our calculation)
• PlexusDx (all doses): $189/month = $2,268 total (our calculation)
• Difference: PlexusDx costs $90/month more, or $1,080 more over 12 months (our calculation)

Tirzepatide, 12 months, assuming Mochi's $39 first-month membership (refill rate unconfirmed) continues:

• Mochi Health (starting dose): $129/month effective = $1,548 total (our calculation)
• PlexusDx (all doses): $289/month = $3,468 total (our calculation)
• Difference: PlexusDx costs $160/month more, or $1,920 more over 12 months (our calculation)

Critical qualifier: These calculations hold only if you remain at Mochi's starting dose for 12 months and the $39 first-month membership rate does not increase. Most patients escalate their dose over the first months of treatment. As soon as your Mochi medication cost rises above $60/month (semaglutide) or $90/month (tirzepatide), the gap narrows. Without published pricing at higher doses, you cannot predict your actual 12-month spend on Mochi before starting treatment.

Service and support: Trustpilot profiles

Mochi Health holds a 4.5-star rating on Trustpilot from approximately 18,000 reviews (captured September 4, 2026). That volume and average place it among the highest-rated telehealth GLP-1 providers by review count. One individual Trustpilot report captured in our research alleges a provider appearing late and not engaging during a consultation; we report this as a single anecdote, not verified as typical or representative of the broader service experience.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). The profile is smaller in volume than Mochi's but demonstrates strong satisfaction among recent patients.

Neither provider's review evidence suggests systemic service failures. Mochi's larger sample and marginally higher average give it a narrow edge in this comparison; PlexusDx's high five-star concentration shows consistent positive experience among a growing base.

Decision factors: per-dose flexibility vs flat-rate predictability

Mochi Health's advantages

• Lowest documented entry price: $99/month semaglutide and $129/month tirzepatide at starting doses (including first-month membership) undercut every flat-rate provider in this comparison by $90–$200/month.
• Per-dose alignment: If your clinician determines you respond well at a low dose and you do not escalate, you avoid paying for dose capacity you do not use.
• Strong review profile: 4.5 stars from ~18,000 Trustpilot reviews (captured September 4, 2026) reflects broad patient experience.

Mochi Health's limitations and transparency gaps

• Unknown ongoing membership cost: The $39 membership is labeled "first month" in captured materials (September 4, 2026); the rate after month one is not published, preventing accurate multi-month cost modeling.
• Unpublished escalation pricing: Evidence confirms that medication cost increases with dose but does not document the price at any dose tier above starting. A patient escalating to maintenance cannot predict their monthly cost without contacting Mochi directly.
• Cost uncertainty through treatment: The combination of unknown membership continuation and unpublished dose-tier pricing means you know only your first-month cost with confidence. Total treatment cost depends on variables not disclosed upfront.

PlexusDx and flat-rate competitors: structural clarity

• Predictable cost at all doses: PlexusDx ($189 sema, $289 tirz), Embody ($299 sema, $349 tirz), Peak Wellness ($249 sema, $349 tirz), and others charge one published rate whether you remain at starting dose or escalate to maximum. You know your 12-month cost before starting.
• No membership ambiguity: Most flat-rate providers either bundle everything into one charge or clearly separate and publish both medication and membership rates with no promotional-period question.
• Multi-month discounts: PlexusDx offers 3-month ($169 sema, $269 tirz per month prepaid) and 6-month ($149 sema, $249 tirz per month prepaid) plans. Found, TrimRx, and Peak Wellness offer similar prepaid structures. These discounts bring per-month rates closer to or below Mochi's starting-dose rate—if Mochi's cost increases meaningfully with dose escalation.

Choose Mochi Health if…

You prioritize the lowest possible entry price, are comfortable confirming membership terms and dose-tier pricing directly with the provider before committing, and prefer a per-dose model that may offer savings if you remain at a low dose long-term. Mochi's 4.5-star Trustpilot profile and ~18,000 reviews suggest most patients experience reliable service. The structure works best for patients willing to accept cost uncertainty in exchange for a lower starting point and the possibility that their dose stays low.

Choose a flat-rate provider (PlexusDx, Embody, Peak, others) if…

You want to know your exact monthly cost at every stage of treatment—starting dose, escalation, and maintenance—before you commit. Flat-rate plans eliminate guesswork: the price you see is the price you pay regardless of dose changes. PlexusDx's $189/month semaglutide and $289/month tirzepatide include medication, clinical access, and shipping with no membership fee or hidden dose charges. Multi-month prepaid discounts (3-month: $169 sema, $269 tirz; 6-month: $149 sema, $249 tirz per month) bring the effective rate closer to Mochi's starting-dose rate while preserving dose-escalation protection. This structure suits patients who value budget predictability and transparent total cost over the lowest possible first-month price.

Where PlexusDx fits in the low-cost field

PlexusDx's $189 semaglutide month-to-month rate sits at the low end of the flat-rate range ($189–$299 across verified competitors, captured July 17–23, 2026) and $90/month above Mochi's starting-dose floor (assuming Mochi's $39 first-month membership continues at the same rate). The $289 tirzepatide rate similarly falls at the low end of flat-rate tirzepatide pricing ($289–$399) and $160/month above Mochi's starting tirzepatide dose.

The trade-off is structural certainty. A patient on PlexusDx pays the same $189 or $289 whether their clinician keeps them at starting dose or escalates to the maximum compounded tier. A patient on Mochi pays less initially but faces an unknown cost curve as dose increases. If you escalate and Mochi's per-dose pricing rises meaningfully—evidence suggests it does but does not quantify the increase—the gap between Mochi's cost and PlexusDx's flat rate narrows or closes.

PlexusDx's 3-month and 6-month prepaid options deliver per-month rates ($169 and $149 semaglutide; $269 and $249 tirzepatide, respectively) that approach or fall below where Mochi's escalated per-dose cost likely lands for many patients, while preserving the flat-rate guarantee. Our 4.3-star Trustpilot rating (79% five-star, 83% four-star or higher, captured September 9, 2026) reflects consistent patient satisfaction; Mochi's 4.5-star profile from a larger sample is marginally stronger, though both providers demonstrate reliable service.

For patients who know they want semaglutide or tirzepatide, expect to escalate dose per clinical protocol, and prefer one predictable charge over variable month-to-month billing, PlexusDx and other flat-rate providers offer measurable planning advantages despite a higher starting price than Mochi's entry tier.

Methodology and freshness

Mochi Health pricing ($60 semaglutide medication starting dose, $90 tirzepatide medication starting dose, $39 first-month membership, per-dose escalation model) captured September 4, 2026 from joinmochi.com/blog/per-dose-pricing-mochi-health and joinmochi.com/medications/compounded-tirzepatide. Mochi's 4.5-star Trustpilot rating (~18,000 reviews) captured September 4, 2026. PlexusDx pricing ($189 semaglutide MTM, $289 tirzepatide MTM, $169/$149 sema and $269/$249 tirz on 3-/6-month prepaid) captured July 17–23, 2026 from plexusdx.com/pages/glp-1-alternatives and internal price sheets; confirmed current as of September 22, 2026. PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four-star+) captured September 9, 2026 from trustpilot.com/review/plexusdx.com.

Benchmark competitor rates (Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx) captured July 17–23, 2026 via checkout verification or published pricing pages. TrimRx advertised rates ($199 sema, $349 tirz) and checkout-verified ongoing rates ($299 sema, $399 tirz) both captured July 2026; we use the checkout-verified figures for like-for-like comparisons. Found's 12-month prepaid plan at $169/month semaglutide when paid upfront is labeled as a prepaid per-month rate (our calculation); Found's standard month-to-month cash-pay rate is $289 semaglutide, $359 tirzepatide.

All 12-month totals, effective monthly rates, and cost-difference figures are our calculations derived from the captured per-month rates and the specified commitment structure. Mochi Health's ongoing membership rate after the first month, and medication pricing at dose tiers above starting dose, were not published in captured sources as of September 4, 2026; we note these gaps explicitly in the analysis and advise readers to confirm terms at checkout.

No promotional codes, referral incentives, or affiliate relationships influenced this comparison. We applied identical evidence and verification standards to PlexusDx and competing providers.

Frequently Asked Questions

Does Mochi Health's per-dose pricing stay at $60 or $90 per month?

No. Mochi's model explicitly states that medication cost increases as your clinician escalates your dose. The $60/month semaglutide and $90/month tirzepatide figures (captured September 4, 2026) apply only to starting doses. Pricing at higher dose tiers was not published in available materials; contact Mochi directly to confirm your cost if your clinician raises your dose.

What is Mochi Health's membership fee after the first month?

The captured evidence labels Mochi's membership as "$39 first month" (September 4, 2026) but does not document the ongoing rate. Confirm at checkout whether the $39 rate continues or increases in subsequent months before committing to treatment.

Can I predict my total 12-month cost on Mochi Health?

Not with published evidence alone. Your total cost depends on (a) whether the $39 first-month membership rate continues beyond month one and (b) how your dose escalates and what Mochi charges at each tier. You can calculate a floor assuming you stay at starting dose and $39 membership ($1,188 over 12 months for semaglutide, our calculation), but most patients escalate, and those higher costs are not published upfront.

How does PlexusDx's flat-rate model work across dose changes?

PlexusDx charges $189/month for compounded semaglutide injection and $289/month for compounded tirzepatide injection regardless of dose. If your clinician starts you at 0.25 mg semaglutide or escalates you to 2.4 mg, the price remains $189. This eliminates cost uncertainty as treatment progresses and simplifies budgeting over 12 months.

Which low-cost provider wins on total cost if I escalate my dose?

It depends on how high Mochi's per-dose pricing rises with escalation—information not published in captured sources. If you remain at starting dose and Mochi's first-month membership stays $39, Mochi offers the lowest documented cost. If you escalate significantly, flat-rate providers (PlexusDx at $189 sema/$289 tirz, Peak Wellness at $249/$349, others) may become equal or lower once Mochi's medication charge increases. Without Mochi's higher-dose pricing, confirm your projected cost with both models before deciding.

Sources

• Mochi Health per-dose pricing announcement, joinmochi.com/blog/per-dose-pricing-mochi-health (accessed September 4, 2026)
• Mochi Health compounded tirzepatide product page, joinmochi.com/medications/compounded-tirzepatide (accessed September 4, 2026)
• Mochi Health main weight-loss page, joinmochi.com/weight-loss (accessed September 4, 2026)
• Mochi Health Trustpilot profile (accessed September 4, 2026)
• PlexusDx GLP-1 alternatives pricing page, plexusdx.com/pages/glp-1-alternatives (accessed July 17–23, 2026; confirmed current September 22, 2026)
• PlexusDx Trustpilot profile, trustpilot.com/review/plexusdx.com (accessed September 9, 2026)
• Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx pricing pages and checkout flows (accessed July 17–23, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.